Juliana Cardoso

Dr. Juliana Cardoso

Institute of Technology and Research - ITP
+1
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2014 in Biofabrication
Verified
Journal Article
Closed access
LBLuiz E Bertassoni
Luiz E Bertassoni
Juliana CardosoJuliana Cardoso
Juliana Cardoso
VMVijayan Manoharan
Vijayan Manoharan
ACAna L Cristino
Ana L Cristino
NBNupura S Bhise
Nupura S Bhise
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini
Fabrication of three dimensional (3D) organoids with controlled microarchitectures has been shown to enhance tissue functionality. Bioprinting can be used to precisely position cells and cell-laden materials to generate controlled tissue architecture. Therefore, it represents an exciting alternative for organ fabrication. Despite the rapid progress in the field, the development of printing processes that can be used to fabricate macroscale tissue constructs from ECM-derived hydrogels has remained a challenge. Here we report a strategy for bioprinting of photolabile cell-laden methacrylated gelatin (GelMA) hydrogels. We bioprinted cell-laden GelMA at concentrations ranging from 7 to 15% with varying cell densities and found a direct correlation between printability and the hydrogel mechanical properties. Furthermore, encapsulated HepG2 cells preserved cell viability for at least eight days following the bioprinting process. In summary, this work presents a strategy for direct-write bioprinting of a cell-laden photolabile ECM-derived hydrogel, which may find widespread application for tissue engineering, organ printing and the development of 3D drug discovery platforms.

1 September 2012 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KRK.R. Riella
K.R. Riella
RMR.R. Marinho
R.R. Marinho
JSJ.S. Santos
J.S. Santos
PFPereira- Filho
Pereira- Filho
Juliana CardosoJuliana Cardoso
Juliana Cardoso
STSara Thomazzi
Sara Thomazzi

1 September 2015 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RCRodrigo Lima Cavendish
Rodrigo Lima Cavendish
JSJandson de Souza Santos
Jandson de Souza Santos
RNReinaldo Belo Neto
Reinaldo Belo Neto
APAilma Oliveira Paixão
Ailma Oliveira Paixão
JOJuciele Valéria Oliveira
Juciele Valéria Oliveira
MGMargarete Zanardo Gomes
Margarete Zanardo Gomes

1 October 2011 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
MDM.D.M. Dantas
M.D.M. Dantas
DCD.R.R. Cavalcante
D.R.R. Cavalcante
FAF.E.N. Araújo
F.E.N. Araújo
SBS.R. Barretto
S.R. Barretto
GAG.T.S. Aciole
G.T.S. Aciole
RAR.L.C. Albuquerque
R.L.C. Albuquerque

1 November 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
PNPaula Nunes
Paula Nunes
ARAlessandra Silva Rabelo
Alessandra Silva Rabelo
JSJamille Cristina Campos de Souza
Jamille Cristina Campos de Souza
BSBruno Vasconcelos Santana
Bruno Vasconcelos Santana
TSThailson Monteiro Menezes da Silva
Thailson Monteiro Menezes da Silva
AAAdriano Antunes de Souza Araújo
Adriano Antunes de Souza Araújo

13 July 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
TSTárcio Santos
Tárcio Santos
TSTarcisio M. Silva
Tarcisio M. Silva
Juliana CardosoJuliana Cardoso
Juliana Cardoso
RARicardo L. C. de Albuquerque-Júnior
Ricardo L. C. de Albuquerque-Júnior
AZAleksandra Zielińska
Aleksandra Zielińska
MMMarcelo da Costa Mendonça
Marcelo da Costa Mendonça
Silver nanoparticles are widely used in the biomedical and agri-food fields due to their versatility. The use of biological methods for the synthesis of silver nanoparticles has increased considerably due to their feasibility and high biocompatibility. In general, microorganisms have been widely explored for the production of silver nanoparticles for several applications. The objective of this work was to evaluate the use of entomopathogenic fungi for the biological synthesis of silver nanoparticles, in comparison to the use of other filamentous fungi, and the possibility of using these nanoparticles as antimicrobial agents and for the control of insect pests. In addition, the in vitro methods commonly used to assess the toxicity of these materials are discussed. Several species of filamentous fungi are known to have the ability to form silver nanoparticles, but few studies have been conducted on the potential of entomopathogenic fungi to produce these materials. The investigation of the toxicity of silver nanoparticles is usually carried out in vitro through cytotoxicity/genotoxicity analyses, using well-established methodologies, such as MTT and comet assays, respectively. The use of silver nanoparticles obtained through entomopathogenic fungi against insects is mainly focused on mosquitoes that transmit diseases to humans, with satisfactory results regarding mortality estimates. Entomopathogenic fungi can be employed in the synthesis of silver nanoparticles for potential use in insect control, but there is a need to expand studies on toxicity so to enable their use also in insect control in agriculture.